EANS-News: Hönle achieves a record result of EUR 0.89 per share

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

annual result

Graefeling/Munich (euro adhoc) - According to preliminary figures,
Hönle Group achieved revenue of EUR 54.6 million (PY: EUR 45.0 m.) in
financial year 2009/2010. The operating result (EBIT) jumped from EUR
-3.9 million in the previous year to EUR 5.5 million in the financial
year ended, and the Group result rose from EUR -4.1 million to EUR
4.8 million. The earnings per share amounted to EUR 0.89 (PY: EUR
-0.80). In the fourth quarter also, Hönle profits from the economic
upswing that has spread to all business segments. Revenue rose from
EUR 11.4 million in the previous year´s quarter to EUR 15.6 million
in the fourth quarter of the reporting year, and the operating result
increased from EUR -1.9 million to EUR 2.6 million in the same
period. The Hönle Group´s liquid assets grew in financial year
2009/2010 and came to EUR 6.7 million as at 30 September 2010. The
equity capital ratio stood at 69.2 %.

The Dr. Hönle AG Management Board and Supervisory Board intend to
have their shareholders participate in the corporate success and will
suggest to the General Meeting that a dividend of at least EUR 0.25
per share be paid out.

Outlook: As recently announced, Dr. Hönle AG acquired a 51 % stake in
UV-Technik Speziallampen GmbH, Wulmbach, Ilmenau. UV-Technik
Speziallampen GmbH has many years of know-how in the segment of UV
lamps that are used in the water sterilisation market, in particular.
Hönle opens up to a sustainable growth in the life science market.

The Management Board aims at increasing consolidated revenues to EUR
65 million and the operating result (EBIT) to EUR 7.5 million in
financial year 2010/211, including the effects of the most recent
acquisition.

The sustained economic upswing, which has meanwhile spread to all of
Hönle Group´s sales markets, will impact positively on business
development. Management assumes that the upturn in the adhesives
segment will continue. In the growth market for UV-based digital
printing, Hönle expects positive development in the orders position
and a revenue increase in financial year 2010/2011. In special
equipment engineering which encompasses the fields of sterilisation
and sunlight simulation, Management likewise expects positive revenue
development. Moreover, Hönle will benefit from the expected pick-up
in offset printing and will sell more UV systems than in the past
financial year.

About Hönle: Dr. Hönle AG is a listed technology company with
registered head office in Gräfelfing, near Munich. With a staff level
of about 300 employees, the Hönle Group is one of the world´s leading
systems suppliers in the UV technology segment. The equipment and
systems are used for drying inks and coatings, curing adhesives and
plastics, disinfecting and in the simulation of natural sunlight. The
Company´s business activities focus also on the development and sale
of industrial adhesives and compounds. The Group is represented by
own companies and sales partners worldwide at 50 locations in more
than 20 countries.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Peter Weinert

Tel.: +49 89 85608 173

E-Mail: peter.weinert@hoenle.de

Web: www.hoenle.com

Branche: Instrument Engineering
ISIN: DE0005157101
WKN: 515710
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade